Reliable, accessible and frequent SARS-CoV-2 rapid testing with Sofia®

Automated and objective results in 15 minutes at the point-of-care

Find out more

To defeat the virus, you must first know where it is.

Our proprietary tracking and mapping system for COVID-19, Flu, RSV, and more.

Lyra® and Lyra Direct SARS-CoV-2 Assays –
Our time-saving, high-throughput, high-quality molecular tests for the detection of COVID-19.

Find out more

COVID-19 can have a significant impact on the Cardiovascular System.

SARS-CoV-2 has been associated with acute and long-term cardiovascular complications.


Revolutionizing medical diagnostics, from cell culture to immunoassays to molecular diagnostics, built for a pandemic, Quidel continues to expand on Point-of-Care (POC) testing solutions to address the needs of physicians and laboratorians globally.

TOGETHER AGAIN

Expanding access to COVID-19 testing to nursing homes throughout the U.S.A.

Providing healthcare workers with confidence in their ability to test for COVID-19.


The ability to quickly and accurately test staff, residents and visitors is an important step toward the long-awaited reunion of residents with their loved ones.

Why Lyme disease could be worse this year.

Ticks don’t know the meaning of “Social Distancing.”


With “normal” activities limited, more families will take to the outdoors, the only thing, ticks don’t play by our rules, so Lyme disease could end up on the rise.

COVID-19 related hospitalizations could bring C. difficile.


An influx of COVID-19 related hospitalizations brings patients presenting a spectra of symptoms, requiring a spectra of treatments – this convergence could lead to an increased risk of C.difficile.

C. difficile could be coming in
with your COVID patients.

From cell culture to immunoassays to molecular diagnostics, Quidel continues to expand on Point-of-Care (POC) testing solutions to address the needs of physicians and laboratorians globally.